Grignon D J, Banerjee D
J Urol. 1987 Feb;137(2):330-2. doi: 10.1016/s0022-5347(17)44016-x.
Cross reactions between monoclonal T-cell antibodies and non-lymphoid tissues have rarely been reported. In this study 28 samples of prostatic tissue obtained at the time of autopsy or surgery, two samples of metastatic prostatic carcinoma and a series of other tumours were snap frozen and sections reacted with a series of monoclonal antibodies directed against the following antigens: Leu 1, Leu 4, T3, T8, T4, T11 and B4. Reactions were detected with an indirect immunofluorescent method. In 10 of 11 normal prostates, 15 of 15 with nodular hyperplasia and 3 of 4 prostatic adenocarcinomas a strong positive reaction occurred with anti-Leu 4. All other antibodies tested were negative. Other tumours tested, including primary carcinomas of lung (2), kidney (3), stomach (1), colon (1), pancreas (1), breast (2), urinary bladder (1), esophagus (1), larynx (1) and malignant melanoma (2), were negative with all antibodies. This is, to our knowledge, the first report of cross reactivity between a monoclonal pan T-cell antibody and epithelium. This cross reaction may be related to a shared antigen between T-cells and prostate epithelial cells or, more likely, it represents reactivity with a shared epitope. Knowledge of this reaction will prevent possible misinterpretations in the evaluation of undifferentiated neoplasms.
单克隆T细胞抗体与非淋巴组织之间的交叉反应鲜有报道。在本研究中,对28份尸检或手术时获取的前列腺组织样本、2份转移性前列腺癌样本以及一系列其他肿瘤样本进行速冻处理,切片后与一系列针对以下抗原的单克隆抗体反应:Leu 1、Leu 4、T3、T8、T4、T11和B4。采用间接免疫荧光法检测反应情况。在11份正常前列腺组织中的10份、15份结节性增生组织中的15份以及4份前列腺腺癌组织中的3份中,抗Leu 4出现强阳性反应。所有其他检测抗体均为阴性。所检测的其他肿瘤,包括肺癌(2例)、肾癌(3例)、胃癌(1例)、结肠癌(1例)、胰腺癌(1例)、乳腺癌(2例)、膀胱癌(1例)、食管癌(1例)、喉癌(1例)和恶性黑色素瘤(2例),所有抗体检测结果均为阴性。据我们所知,这是单克隆全T细胞抗体与上皮之间交叉反应的首次报道。这种交叉反应可能与T细胞和前列腺上皮细胞之间共享的抗原有关,或者更有可能是与共享的表位发生反应。了解这种反应将避免在未分化肿瘤评估中可能出现的错误解读。